Bodyrich Plus logo

Bodyrich Plus – Concept Biosciences

Registered App ID 4186407 Class 5 Device

Trademark information

IP India · live record
Application ID
4186407
Status
Registered
Sub status
Not Applicable
Date of application
24 May 2019
Classes
5
Type
Device
Proprietor
Concept Biosciences Private 1 A.J.C Bose Road, 3 Rd Floor, Kolkata 700020, Wb
Attorney
Ipm Services[17106]Nowapara,New Town,Kolkata 700 157,West Bengal,India.
State
West Bengal
Filing mode
e-Filing
IP office
Kolkata
Used since
—
Valid / upto
24 May 2029

Goods & services

Class 5

Class 5PHARMACEUTICAL PREPARATIONS FOR MEDICAL USE IN THE FORM OF TABLETS, CAPSULES, SYRUPS, OINTMENT & INJECTIONS INCLUDED IN CLASS 05IN CLASS 05

Mark image

Device

Uploaded documents

Sign in to open
1 TM-A(TRADE MARKS APPLICATION) 24 May 2019
2 REPLY TO FORMALITY CHECK(MIS-F) 15 Jul 2019
3 Reply to Exam Report (MIS-R) 16 Aug 2019
4 Authorization Letter 24 Jun 2021
5 Documents in support of Show cause Hearing (SCH) 21 Jul 2021
6 Reply to Exam Report (MIS-R) 28 Oct 2022
7 Authorization Letter 02 Jun 2025
8 Journal Copy 19 Jun 2025
9 Certificate 02 Nov 2025

Correspondence and notices

1 Application(4186407) Keep Pending 8495573 · 4197957 26 Jun 2019
2 EXAMINATION REPORT 8722515 06 Aug 2019
3 Hearing Notice (Show Cause) 11606339 07 Jun 2021
4 Hearing Notice (Show Cause) 11956455 06 Aug 2021
5 Hearing Notice (Show Cause) 12396653 30 Oct 2021
6 Hearing Notice (Show Cause) 12922414 01 Feb 2022
7 Hearing Notice (Show Cause) 13593479 03 Jun 2022
8 EXAMINATION REPORT 14268492 28 Oct 2022
9 EXAMINATION REPORT 14268493 28 Oct 2022
10 EXAMINATION REPORT 14268495 28 Oct 2022
11 Hearing Notice for Application No. 4186407 20147884 01 May 2025
12 Tribunal Accepted Notice for : 4186407 20353479 · 7273883 05 Jun 2025

Frequently asked questions

Bodyrich Plus was applied for on 24 May 2019.

The application was filed by Concept Biosciences.

Class 5.

As per IP India, the status is Registered.

The listed application ID of Bodyrich Plus is 4186407.

Trademark attorney Ipm Services.